GLYTR THERAPEUTICS

GlyTR Therapeutics develops a novel immunotherapy platform technology targeting diverse cancer types, from breast cancer to leukemia. The company is based on research that has come out of UC Irvine’s Research Lab and founded by Dr. Michael Demetriou and Dr. Raymond Zhou.

#SimilarOrganizations #People #Financial #Website #More

GLYTR THERAPEUTICS

Social Links:

Facebook

Industry:

Biotechnology Health Diagnostics Medical Therapeutics

Founded:

2015-01-01

Address:

Irvine, California, United States

Country:

United States

Website Url:

http://www.glytrtherapeutics.com

Total Employee:

1+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

0

Similar Organizations

candel-therapeutics-logo

Candel Therapeutics

Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Advisors List

bob-genthert_image

Bob Genthert Member of Board of Directors @ GlyTR Therapeutics
Board_member
2017-09-01

Current Employees Featured

raymond-zhou_image

Raymond Zhou
Raymond Zhou Founder @ GlyTR Therapeutics
Founder
2015-01-01

not_available_image

Michael Demetriou
Michael Demetriou Founder @ GlyTR Therapeutics
Founder
2015-01-01

Founder

not_available_image

Michael Demetriou

raymond-zhou_image

Raymond Zhou

Investors List

evonexus-llc_image

EvoNexus

EvoNexus investment in Non Equity Assistance - GlyTR Therapeutics

Official Site Inspections

http://www.glytrtherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "GlyTR Therapeutics" on Search Engine